Intensive insulin therapy in critically ill hospitalized patients: Making it safe and effective

Journal of Diabetes Science and Technology

Volumn 5, Issue 3, 2011, Pages 755-767

  Klonoff, David C ^a  

^a DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Critical care; Glucose; Glucose monitoring; Glucose variability; Hyperglycemia; Hypoglycemia; Insulin; Intensive; Intensive care unit; Point of care

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

ANALYZER; ARTIFICIAL VENTILATION; BLOOD ANALYSIS EQUIPMENT; BLOOD GAS ANALYSIS; BLOOD GAS ANALYZER; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITOR; BLOOD GLUCOSE MONITORING; CRITICALLY ILL PATIENT; DIABETIC PATIENT; DRUG OVERDOSE; DYSGLYCEMIA; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTENSIVE INSULIN THERAPY; MEDICATION ERROR; META ANALYSIS; META ANALYSIS (TOPIC); MONITOR; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); PATIENT MONITORING; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; RISK REDUCTION; SURGICAL INFECTION; CHEMISTRY; CLINICAL TRIAL (TOPIC); CRITICAL ILLNESS; DRUG TOXICITY; HOSPITALIZATION; METHODOLOGY; TREATMENT OUTCOME;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DRUG TOXICITY; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; TREATMENT OUTCOME;

EID: 82155187789     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500330     Document Type: Review

References (83)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596-615.
2. Wexler DJ, Nathan DM, Grant RW, Regan S, Van Leuvan AL, Cagliero E. Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocrinol Metab. 2008;93(11):4238-44. (Pubitemid 352789517)
3. Mazurek JA, Hailpern SM, Goring T, Nordin C. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab. 2010;95(3):1344-8.
4. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-82. (Pubitemid 36121050)
5. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146(1):30-4. (Pubitemid 40091727)
6. Sleiman I, Morandi A, Sabatini T, Ranhoff A, Ricci A, Rozzini R, Trabucchi M. Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit. J Am Geriatr Soc. 2008;56(6):1106-10. (Pubitemid 351782743)
7. Rogers SO Jr, Zinner MJ. The role of perioperative hyperglycemia in postoperative infections. Adv Surg. 2009;43:103-9.
8. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes. Eur J Cardiovasc Prev Rehabil. 2010;17(4):419-23.
9. Parappil A, Depczynski B, Collett P, Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010;15(6):918-22.
10. Corathers SD, Falciglia M. The role of hyperglycemia in acute illness: supporting evidence and its limitations. Nutrition. 2011;27(3):276-81.
11. Merz TM, Finfer S. Pro/con debate: is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients? Crit Care. 2008;12(2):212.
12. Smith FG, Sheehy AM, Vincent JL, Coursin DB. Critical illness-induced dysglycaemia: diabetes and beyond. Crit Care. 2010;14(6):327.
13. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006;34(1):96-101. (Pubitemid 43032385)
14. Brealey D, Singer M. Hyperglycemia in critical illness: a review. J Diabetes Sci Technol. 2009;3(6):1250-60.
15. Sheehy AM, Gabbay RA. An overview of preoperative glucose evaluation, management, and perioperative impact. J Diabetes Sci Technol. 2009;3(6):1261-9.
16. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med. 2011;39(1):105-11.
17. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114(9):1187-95.
18. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995;98(1):75-84.
19. Furnary AP. Clinical benefits of tight glycaemic control: focus on the perioperative setting. Best Pract Res Clin Anaesthesiol. 2009;23(4):411-20.
20. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-61. (Pubitemid 27084552)
21. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352-60.
22. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-21. (Pubitemid 36644877)
23. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
24. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
25. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-44.
26. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-7.
27. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010;137(3):544-51.
28. Friedrich JO, Chant C, Adhikari NK. Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data. Crit Care. 2010;14(5):324.
29. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154(4):268-82.
30. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738-48.
31. Dandona P, Chaudhuri A, Dhindsa S. Insulin infusion and hypoglycemia: clinical implications and prevention. Crit Care Med. 2010:38(6):1490-1.
32. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
33. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
34. Gunst J, Van den Berghe G. Blood glucose control in the intensive care unit: benefits and risks. Semin Dial. 2010;23(2):157-62.
35. Scurlock C, Raikhelkar J, Mechanick JI. Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)--a review of recent literature. Curr Opin Clin Nutr Metab Care. 2010;13(2):211-4.
36. COIITSS Study Investigators, Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303(4):341-8.
37. Moghissi ES. Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets. Am J Health Syst Pharm. 2010;67(16 Suppl 8):S3-8.
38. Kane-Gill SL, Van Den Bos J, Handler SM. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database. Ann Pharmacother. 2010;44(6):983-93.
39. U.S. Pharmacopeia. USP Patient Safety CAPSLink. United States Pharmacopeial Convention, Inc. July 2003. http://www.usp.org/pdf/EN/ patientSafety/capsLink2003-07-01.pdf. Accessed March 10, 2011.
40. Bellomo R, Egi M. Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc. 2005;80(12):1546-8. (Pubitemid 41747054)
41. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-7. (Pubitemid 38174072)
42. Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77-82.
43. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28 Suppl 1:S4-36.
44. The Endocrine Society. Endocrine Society statement to providers on NICE-SUGAR. http://www.endo-society.org/advocacy/legislative/ SocietyStatementtoProvidersonNICE-SUGAR.cfm. Accessed November 28, 2010.
45. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353-69.
46. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119-31.
47. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154(4):260-7.
48. American Association of Clinical Endocrinologists. Insulin therapy for hospitalized patients should not be abandoned: the American Association of Clinical Endocrinologists and the American Diabetes Association joint statement in response to American College of Physicians (ACP) clinical guidelines for inpatient glucose control. http://media.aace.com/article-display.cfm?article-id= 5022 . Accessed March 10, 2011.
49. The Endocrine Society. Endocrine Society supports rational glycemic management over intensive insulin therapy in hospitalized patients. http://www.endo-society.org/media/press/2011/ SocietySupportsRationalGlycemicManagementover. cfm . Accessed March 10, 2011.
50. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094-100.
51. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 2009;3(6):1292-301.
52. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-42.
53. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38(4):1021-9.
54. Krinsley JS. Glycemic variability in critical illness and the end of Chapter 1. Crit Care Med. 2010;38(4):1206-8.
55. Egi M, Bellomo R. Reducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol. 2009;3(6):1302-8.
56. Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, Schultz MJ. Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med. 2010;36(9):1556-65.
57. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology. 2009;110(2):408-21.
58. Khan AI, Vasquez Y, Gray J, Wians FH Jr, Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med. 2006;130(10):1527-32. (Pubitemid 44520721)
59. Rice MJ, Pitkin AD, Coursin DB. Review article: glucose measurement in the operating room: more complicated than it seems. Anesth Analg. 2010;110(4):1056-65.
60. Pitkin AD, Rice MJ. Challenges to glycemic measurement in the perioperative and critically ill patient: a review. J Diabetes Sci Technol. 2009;3(6):1270-81.
61. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, Meertens JH, Zijlstra JG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care. 2006;10(5):R135.
62. Malone B. Blood glucose meters: is FDA ready to tighten up accuracy standards? Clin Lab News. 2010;36(5):1-4.
63. Alter D, Deines G. Tight glycemic control and point-of-care testing. Clin Lab Med. 2009;29(3):511-22.
64. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med. 2009;37(5):1769-76.
65. Klonoff DC. The Food and Drug Administration is now preparing to establish tighter performance requirements for blood glucose monitors. J Diabetes Sci Technol. 2010;4(3):499-504.
66. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971-80.
67. Stahl M, Brandslund I, Jørgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest. 2002;62(2):159-66. (Pubitemid 34407553)
68. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005;33(12):2778-85. (Pubitemid 41816412)
69. Karon BS, Gandhi GY, Nuttall GA, Bryant SC, Schaff HV, McMahon MM, Santrach PJ. Accuracy of Roche Accu-Chek Inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol 2007;127(6):919-26.
70. Mraovic B. Analysis: continuous glucose monitoring during intensive insulin therapy. J Diabetes Sci Technol. 2009;3(4):960-3.
71. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009;3(6):1309-18.
72. Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovic L, Chase HP, Wilson DM, Buckingham BA, Doyle FJ 3rd. Real-time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care. 2010;33(6):1249-54.
73. Davey RJ, Jones TW, Fournier PA. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol. 2010;4(6):1457-64.
74. Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010;14(5):R176.
75. Clarke WL, Kovatchev B. Continuous glucose sensors: continuing questions about clinical accuracy. J Diabetes Sci Technol.2007;1(5):669-75.
76. Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H, Madl C. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33(3):467-72.
77. Mastrototaro J, Welsh JB, Lee S. Practical considerations in the use of real-time continuous glucose monitoring alerts. J Diabetes Sci Technol 2010;4(3):733-9.
78. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol 2010;4(6):1540-62.
79. Valgimigli F, Lucarelli F, Scuffi C, Morandi S, Sposato I. Evaluating the clinical accuracy of GlucoMen® Day: a novel microdialysis-based continuous glucose monitor. J Diabetes Sci Technol 2010;4(5):1182-92.
80. Magarian P, Sterling B. Plasma-generating glucose monitor accuracy demonstrated in an animal model. J Diabetes Sci Technol. 2009;3(6):1411-8.
81. Davidson PC, Steed RD, Bode BW, Hebblewhite HR, Prevosti L, Cheekati V. Use of a computerized intravenous insulin algorithm within a nurse-directed protocol for patients undergoing cardiovascular surgery. J Diabetes Sci Technol. 2008;2(3):369-75.
82. Choudhary P, Amiel SA. The use of technology to reduce hypoglycemia. Pediatr Endocrinol Rev. 2010:7 Suppl 3:384-95.
83. Klonoff DC, Cobelli C, Kovatchev B, Zisser HC. Progress in development of an artificial pancreas. J Diabetes Sci Technol. 2009;3(5):1002-4.